Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
May 1 NBIX Neurocrine Q1 revenue beats Street, gets FDA okay for Ingrezza Sprinkle
May 1 NBIX Neurocrine Biosciences, Inc. (NBIX) Q1 2024 Earnings Call Transcript
May 1 NBIX Why Things Are Looking Up For IBD Stock Of The Day Neurocrine, A Top 1% Biotech
May 1 REGN Regeneron Pharmaceuticals Q1 2024 Earnings Preview
May 1 NBIX Neurocrine (NBIX) Reports Q1 Earnings: What Key Metrics Have to Say
May 1 NBIX Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates
May 1 NBIX Neurocrine Biosciences Non-GAAP EPS of $1.20 misses by $0.09, revenue of $515.3M beats by $3.29M
May 1 NBIX Neurocrine Biosciences Reports First Quarter 2024 Financial Results
May 1 REGN Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
Apr 30 NBIX UPDATE 2-Neurocrine Biosciences' Huntington's disease drug gets FDA approval
Apr 30 NBIX Neurocrine Biosciences Announces U.S. FDA Approval of INGREZZA® SPRINKLE (valbenazine) Capsules
Apr 30 NBIX Neurocrine Biosciences Q1 2024 Earnings Preview
Apr 30 REGN Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Apr 30 NBIX Curious about Neurocrine (NBIX) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Apr 30 REGN Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Apr 30 XOMA XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
Apr 29 MESO Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 MESO Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Apr 29 REGN Down -8.24% in 4 Weeks, Here's Why Regeneron (REGN) Looks Ripe for a Turnaround
Apr 29 REGN Countdown to Regeneron (REGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags